|
Market Closed -
Nasdaq
04:00:00 2026-08-26 pm EDT
|
After hours 04:32:07 pm | |||
| 148.09 USD | -0.46% |
|
148.70 | +0.41% |
| Aug. 25 | Wall Street Wants Receipts |  |
| Aug. 25 | Lakefront Biotherapeutics, Gilead Secure Another Orphan Drug Designation for Skin Disorder Drug in US | MT |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | -0.46% | +0.33% | +13.46% | +10.74% | +20.65% | +29.05% | +92.22% | +107.32% | +85.65% | 184B | |
| -3.59% | -7.10% | -0.68% | +11.71% | +10.68% | +61.60% | +114.73% | +355.15% | +1,420.21% | 1,100B | |
| -1.15% | -1.25% | +1.52% | +17.30% | +30.47% | +52.98% | +64.34% | +55.80% | +126.81% | 658B | |
| -1.09% | -1.15% | +2.33% | +23.36% | +15.06% | +26.18% | +78.32% | +118.36% | +306.90% | 470B | |
| -1.47% | +2.05% | +3.72% | +10.10% | +12.22% | +41.71% | +42.09% | +1.70% | +53.27% | 372B | |
| -0.90% | +1.29% | +0.22% | +6.46% | +16.04% | +25.62% | +41.75% | +51.73% | +64.53% | 304B | |
| -1.94% | +1.53% | -5.07% | -12.36% | -11.28% | +3.05% | +13.24% | +42.59% | +146.90% | 264B | |
| -0.43% | -0.46% | +17.03% | +31.08% | +34.53% | +52.06% | +71.64% | +98.83% | +156.06% | 239B | |
| -0.93% | +2.90% | -4.88% | +5.52% | -6.24% | -16.98% | -52.28% | -6.71% | +95.73% | 213B | |
| -0.95% | +0.21% | +14.71% | +9.48% | +13.65% | +13.56% | -21.84% | -40.27% | -18.72% | 163B | |
| -1.01% | -0.86% | +14.26% | +25.55% | +20.72% | +41.35% | +55.66% | +176.06% | +463.69% | 140B | |
| -0.52% | -0.06% | +8.01% | +16.44% | +25.27% | +43.13% | +9.62% | +0.87% | +14.97% | 139B | |
| -0.57% | +0.80% | +2.97% | +1.07% | -5.36% | -9.24% | -20.69% | -11.07% | +14.18% | 110B | |
| -0.31% | -0.86% | -3.14% | -1.32% | +4.11% | +29.26% | +35.89% | +2.77% | -7.88% | 104B | |
| +1.45% | +2.41% | +2.96% | -7.05% | -14.46% | +17.30% | +59.78% | +64.55% | +553.88% | 71.79B | |
| +0.81% | +1.58% | +1.58% | +15.81% | +21.20% | +33.12% | +31.04% | +59.89% | +30.54% | 58.27B | |
| -0.30% | +0.76% | +6.62% | +27.86% | +32.69% | +74.74% | -1.88% | +2.81% | -48.87% | 56.48B | |
| -0.58% | -11.23% | -13.02% | -5.95% | -21.96% | -29.84% | +14.17% | -1.94% | +183.98% | 45.53B | |
| +1.00% | +4.30% | +0.84% | +9.18% | -0.40% | +4.33% | +14.30% | - | - | 44.39B | |
| -0.47% | +1.20% | +22.01% | +9.56% | +21.50% | +108.93% | +292.14% | +307.74% | -26.44% | 44.4B | |
| Average | -0.57% | +1.95% | +4.27% | +10.23% | +10.95% | +30.10% | +46.71% | +72.96% | +190.28% | 238.98B | |
| Weighted average by Cap. | -1.34% | +2.17% | +2.84% | +12.18% | +13.91% | +37.72% | +60.14% | +124.94% | +433.28% |
- Stock Market
- Stocks
- GILD Stock
- Sector Gilead Sciences, Inc.
Select your edition
All financial news and data tailored to specific country editions
